Lorentzen Henrik F, Weismann Kaare
Odense Universitetshospital, Naevusklinikken, Dermatologisk Afdeling, og Hørsholm Sygehus, Dermatologisk Klinik.
Ugeskr Laeger. 2005 Sep 26;167(39):3696-7.
Imiquimod is an immune system-modifying drug that switches the immune system to a Th1 response, enabling it to defeat virus-infected and neoplastic cells. We report on a 94-year-old woman with a large lentigo maligna (LM) on her cheek whom we treated with imiquimod 5% cream. Dermoscopy was used to identify the most suspect areas of the lesion for biopsy and in follow-up. By week 19 the lesion was cleared, and no remnants of the lesion were seen by dermoscopy or histology. Published LM cases treated with imiquimod are reviewed.
咪喹莫特是一种能调节免疫系统的药物,可使免疫系统转向Th1反应,从而使其能够战胜病毒感染细胞和肿瘤细胞。我们报告了一名94岁女性,其脸颊上有一个巨大的恶性雀斑样痣(LM),我们用5%的咪喹莫特乳膏对其进行治疗。皮肤镜检查用于确定病变中最可疑的区域,以便进行活检和随访。到第19周时,病变已清除,通过皮肤镜检查或组织学检查均未发现病变残留。本文对已发表的用咪喹莫特治疗的LM病例进行了综述。